Provided by Tiger Fintech (Singapore) Pte. Ltd.

GeneDx Holdings

64.43
+0.39000.61%
Pre-market: 65.360.9300+1.44%09:02 EDT
Volume:685.43K
Turnover:44.02M
Market Cap:1.84B
PE:-45.78
High:66.26
Open:63.98
Low:61.55
Close:64.04
Loading ...

GeneDx expands into Inborn Errors of Immunity

TIPRANKS
·
03 Apr

GeneDx Expands Commercial Footprint for Exome and Genome Testing With Inborn Errors of Immunity as a New Indication

THOMSON REUTERS
·
03 Apr

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication

Business Wire
·
03 Apr

Buy 3 Momentum Anomaly Stocks as Markets Rise Despite Tariff Threats

Zacks
·
02 Apr

3 Stocks Estimated To Be Trading At A Discount Of 25.2% To 28.2%

Simply Wall St.
·
25 Mar

Is GeneDx Holdings (WGS) The High Growth Low Debt Stock to Invest in Now?

Insider Monkey
·
23 Mar

BRIEF-GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Reuters
·
21 Mar

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
21 Mar

Is Now The Time To Look At Buying GeneDx Holdings Corp. (NASDAQ:WGS)?

Simply Wall St.
·
18 Mar

Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies

Business Wire
·
18 Mar

BTIG Sticks to Its Buy Rating for GeneDx Holdings (WGS)

TIPRANKS
·
18 Mar

5 Stocks With Recent Price Strength Amid Extreme Volatility

Zacks
·
18 Mar

Is GeneDx Holdings (NASDAQ:WGS) Using Too Much Debt?

Simply Wall St.
·
17 Mar

Is GeneDx Holdings Corp. (WGS) the Best Multibagger Stock to Buy in 2025?

Insider Monkey
·
14 Mar

GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis

Business Wire
·
13 Mar

GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting

Business Wire
·
13 Mar

Is GeneDx Holdings Corp. (WGS) the Best Emerging Technology Stock to Buy Now?

Insider Monkey
·
10 Mar

How This Top Small-Cap Growth Fund Wins Big

Blockhead
·
07 Mar

GeneDx Expanding Genetic Testing to Include Cerebral Palsy

MT Newswires Live
·
04 Mar

GeneDx Expands Commercial Footprint for Exome and Genome Testing With Cerebral Palsy as a New Indication

THOMSON REUTERS
·
04 Mar